Guikai Zhang

Bioengineering Bacterially Derived Immunomodulants: A Therapeutic Approach to Inflammatory Bowel Disease.

J. Champion, R. Sumagin, C. Parkos, 2017, ACS nano.

The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin

C. Hadjipanayis, Fenggui Wei, C. Hao, 2013, BMC Cancer.